Published in BMJ on July 10, 1993
Insulin resistance. BMJ (1996) 1.00
The antihypertensive effect of arginine. Int J Angiol (2008) 0.81
The antihypertensive effect of cysteine. Int J Angiol (2009) 0.77
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22
Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol (1979) 27.52
Immunoassay of insulin with insulin-antibody precipitate. Biochem J (1963) 17.13
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet (1963) 16.71
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest (1985) 3.85
Insulin resistance in essential hypertension. N Engl J Med (1987) 3.78
Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest (1990) 3.74
Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest (1980) 3.10
Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes (1981) 2.89
A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med (1989) 2.79
In defence of insulin: a critique of syndrome X. Lancet (1992) 2.62
Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest (1984) 2.03
Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus. Diabetes (1981) 1.73
In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes (1987) 1.70
The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia (1981) 1.68
Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab (1988) 1.46
Family (parental) history and prevalence of hypertension. Results of a nationwide screening program. JAMA (1979) 1.41
Effects of insulin upon ion transport. Biochim Biophys Acta (1983) 1.25
Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA (1988) 1.25
Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle. J Clin Endocrinol Metab (1991) 1.24
Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens (1989) 1.24
Study of the relationship between glucose and insulin responses to an oral glucose load in man. Diabetes (1968) 1.21
Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med (1991) 1.06
Insulin secretion, insulin resistance, and obesity. Int J Obes (1982) 1.06
Persistent elevation of blood pressure among children with a family history of hypertension: the Minneapolis Children's Blood Pressure Study. J Hypertens (1988) 1.05
Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia (1988) 1.01
Normal coding sequence of insulin gene in Pima Indians and Nauruans, two groups with highest prevalence of type II diabetes. Diabetes (1991) 0.98
Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus. J Clin Invest (1991) 0.96
Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. Diabetes (1989) 0.94
Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension (1991) 0.94
The hemodynamic link between insulin resistance and hypertension. J Hypertens (1991) 0.87
The effects of low dose insulin infusions on the renin angiotensin and sympathetic nervous systems in normal man. Eur J Clin Invest (1991) 0.83
Design and interpretation of studies comparing individuals with and without a family history of high blood pressure. J Hypertens (1986) 0.81
Current knowledge regarding the genetics of human hypertension. J Hypertens Suppl (1989) 0.81
Insulin action and hepatic glucose cycling in essential hypertension. Metabolism (1992) 0.81
Insulin receptor gene polymorphisms in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1991) 0.77
Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ (1992) 26.37
Contribution of isolated general practitioner maternity units. Br Med J (Clin Res Ed) (1984) 4.36
Captopril in the treatment of clinical hypertension and cardiac failure. Lancet (1979) 3.93
Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol (1998) 3.57
Community refinement of glaucoma referrals. Eye (Lond) (2003) 3.47
Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2003) 3.33
A review of the use of health status measures in economic evaluation. Health Technol Assess (1999) 2.62
X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet (1975) 2.57
Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology (Oxford) (1999) 2.51
Flow cytometric analysis does not reliably differentiate benign from malignant phaeochromocytoma. Clin Endocrinol (Oxf) (1996) 2.00
Economic aspects of reduced smoking. Lancet (1977) 1.98
Can we prevent accidental injury to adolescents? A systematic review of the evidence. Inj Prev (1995) 1.96
Long-term glycaemic control and diabetic retinopathy. Lancet (1989) 1.87
Personal telephone electrocardiogram transmitter. Lancet (1973) 1.86
Control of smoking and price of cigarettes--a comment. Br J Prev Soc Med (1974) 1.83
Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J (Clin Res Ed) (1982) 1.76
Addison's disease presenting as reduced insulin requirement in insulin dependent diabetes. BMJ (1996) 1.71
Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet Med (1998) 1.69
Combined treatment of severe intractable hypertension with captopril and diuretic. Lancet (1980) 1.68
Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab (2001) 1.64
Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study. Diabetes Care (1997) 1.64
Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest (1986) 1.61
Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension. BMJ (1994) 1.60
Runaway pacemaker rhythm after 36 hours of electrical inactivity. Br Heart J (1974) 1.60
Insulin dependant diabetes mellitus: implications for male reproductive function. Hum Reprod (2007) 1.55
Intermittent therapy with corticotrophin. Lancet (1966) 1.46
Carcinoma of the thyroglossal duct: case reports and a literature review. Aust N Z J Surg (1993) 1.46
Comparison of effects of captopril used either alone or in combination with a thiazide diuretic on insulin action in hypertensive Type 2 diabetic patients: a double-blind crossover study. Diabet Med (1999) 1.42
Unnecessary delays in accident and emergency departments: do medical and surgical senior house officers need to vet admissions? J Accid Emerg Med (1995) 1.39
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril. Lancet (1979) 1.37
The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families. Nat Genet (1992) 1.35
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Retroperitoneal liposarcoma. Ann Surg (1978) 1.31
Phaeochromocytoma in pregnancy. Five cases and a review of the literature. Br J Obstet Gynaecol (1989) 1.31
Neuroendocrine tumors. A European view. Am J Med (1986) 1.29
rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int (1991) 1.27
Five cases of cyclical Cushing's syndrome. Br Med J (Clin Res Ed) (1985) 1.22
Changes in glucose tolerance and development of gall stones during high dose treatment with octreotide for acromegaly. BMJ (1989) 1.21
Synacthen Depot--Adrenal response in normal subjects and corticotrophin-treated patients. Br Med J (1968) 1.21
Neurological dysfunction in two patients receiving captopril and cimetidine. Lancet (1980) 1.20
Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure. Br J Clin Pharmacol (1982) 1.19
Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size. J Clin Endocrinol Metab (2002) 1.18
Rare germinal unequal crossing-over leading to recombinant gene formation and gene duplication in Arabidopsis thaliana. Proc Natl Acad Sci U S A (1999) 1.17
CD14-independent responses to LPS require a serum factor that is absent from neonates. J Immunol (1995) 1.15
Factors relating to readmission of term and near-term neonates in the first two weeks of life. Early Discharge Survey Group of the Health Professional Advisory Board of the Greater New York Chapter of the March of Dimes. J Perinat Med (1999) 1.15
Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet Med (1999) 1.15
Value of intravenous urography in investigating hypertension. J R Coll Physicians Lond (1974) 1.13
Converting enzyme inhibitors in hypertension and heart failure. Br Heart J (1983) 1.12
The effects of delay in treatment of survival rates in carcinoma of the breast. Med J Aust (1971) 1.11
An exploration of knowledge and attitudes related to pre-pregnancy care in women with diabetes. Diabet Med (2010) 1.11
Evaluation of a DVD for women with diabetes: impact on knowledge and attitudes to preconception care. Diabet Med (2012) 1.09
Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes. Diabet Med (2005) 1.09
Isolation of C. dubliniensis from insulin-using diabetes mellitus patients. J Oral Pathol Med (2000) 1.09
Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment. Diabet Med (1988) 1.08
Individualised patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomised controlled trial. Eye (Lond) (2011) 1.08
Preliminary survey of educational support for patients prescribed ocular hypotensive therapy. Eye (Lond) (2010) 1.07
In vitro synthesis of human immunodeficiency virus-specific antibodies in peripheral blood lymphocytes of infants. Proc Natl Acad Sci U S A (1989) 1.06
Clinical presentation of coeliac disease in adult gastroenterological practice. Ulster Med J (1985) 1.05
Dilation x-ray imager a new∕faster gated x-ray imager for the NIF. Rev Sci Instrum (2012) 1.05
Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome--recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem (1997) 1.05
Results of a European multicentre study with Sandostatin LAR in acromegalic patients. Sandostatin LAR Group. Pituitary (1999) 1.04
Captopril, angiotensin II, and sodium in blood-pressure regulation. Lancet (1979) 1.04
Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis. Clin Endocrinol (Oxf) (2000) 1.03
Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am J Hum Genet (1995) 1.03
The clinical effect of topical phenytoin on wound healing: a systematic review. Br J Dermatol (2007) 1.02
Effects of hyperglycemia on glucose production and utilization in humans. Measurement with [23H]-, [33H]-, and [614C]glucose. Diabetes (1986) 1.01
Papilloedema and hepatic dysfunction apparently induced by perhexiline maleate (Pexid). Br Heart J (1980) 1.01
Tranquillisers and plasma prolactin. Br Med J (1979) 1.01
Establishment of the Melbourne mobile intensive care service. Med J Aust (1975) 1.01
Motor vehicle driving among diabetics taking insulin and non-diabetics. BMJ (1989) 1.00
Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age. Br J Obstet Gynaecol (1984) 1.00
Immunophenotyping of T lymphocytes by three-color flow cytometry in healthy newborns, children, and adults. Clin Immunol Immunopathol (1997) 1.00
Detection of psychiatric disorders in elderly medical inpatients. Age Ageing (1994) 1.00
Quality of life in myopia. Br J Ophthalmol (2000) 0.99
Respiratory behavior in near-miss sudden infant death syndrome. Pediatrics (1982) 0.99
Regulation of the hydrogenase-4 operon of Escherichia coli by the sigma(54)-dependent transcriptional activators FhlA and HyfR. J Bacteriol (2002) 0.99
Relationship of endothelial function to birth weight in humans. Diabetes Care (1999) 0.98
Captopril in a hyponatraemic hypertensive: need for caution in initiating therapy. Lancet (1979) 0.98
Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf) (1992) 0.97
A digital stimulator built on modular principles using integrated circuits. J Physiol (1971) 0.96
Effects of combination therapy with an angiotensin converting enzyme inhibitor and thiazide diuretic on insulin action in essential hypertension. J Hypertens (1998) 0.96
The effect of cortisol on glucose/glucose-6-phosphate cycle activity and insulin action. J Clin Endocrinol Metab (1993) 0.96